Matthijs Van Meerveld, Associate Vice President, Global Head of Patient Advocacy and Policy at Menarini Stemline, shared a post on LinkedIn:
“Exciting news to share: I have assumed additional responsibilities as Global Head of Patient Advocacy and Policy at Menarini Stemline. This new chapter has also brought me to New York City, where I officially moved last week.
I would like to express my deep gratitude to our CEO Elcin Barker Ergun and the senior leadership team for their continued trust and visionary guidance. It is an honor to be part of a company so committed to patients and innovation.
To my incredible team: your passion, creativity, and dedication inspire me every day, and I am so proud of what we are building together. A heartfelt word of thanks to our patient community partners – across metastatic and early breast cancer, hematology, and multiple myeloma. ]I look forward to continuing to learn from you, to support you, and to amplify your voice at every step.
Finally, I am excited to push the boundaries further in the policy realm, helping to pave the way for science, research and innovation, so that together we can deliver more and better treatment options for patients worldwide. Here’s to the journey ahead, grounded in partnership, vision, and purpose.”
More posts featuring Matthijs Van Meerveld on OncoDaily.